Correlation Between Pharvaris and Sana Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Sana Biotechnology, you can compare the effects of market volatilities on Pharvaris and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Sana Biotechnology.

Diversification Opportunities for Pharvaris and Sana Biotechnology

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Pharvaris and Sana is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Pharvaris i.e., Pharvaris and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Pharvaris and Sana Biotechnology

Given the investment horizon of 90 days Pharvaris is expected to generate 441.74 times less return on investment than Sana Biotechnology. But when comparing it to its historical volatility, Pharvaris BV is 10.15 times less risky than Sana Biotechnology. It trades about 0.0 of its potential returns per unit of risk. Sana Biotechnology is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  170.00  in Sana Biotechnology on October 26, 2024 and sell it today you would earn a total of  186.00  from holding Sana Biotechnology or generate 109.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Sana Biotechnology

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Sana Biotechnology 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris and Sana Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Sana Biotechnology

The main advantage of trading using opposite Pharvaris and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.
The idea behind Pharvaris BV and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets